MedTrace Logo

Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis

NCT01149252 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of a new product, Psoralait, as compared to a placebo in the treatment of psoriasis.

Conditions

Interventions

OTHER

Psoralait

Cream to be used as instructed.

OTHER

Placebo cream.

Cream to be used as instructed

Sponsors & Collaborators

  • Trima, Israel Pharmaceutical Products

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01149252 on ClinicalTrials.gov